mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.2 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.2 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |